EverlyWell is a technology company.
EverlyWell has raised $280.0M across 3 funding rounds.
Key people at EverlyWell.
EverlyWell has raised $280.0M in total across 3 funding rounds.
Key people at EverlyWell.
Everlywell is a digital health company that builds at-home lab testing kits and a next-generation AI-powered health platform designed to provide accessible, affordable, and insightful diagnostic testing directly to consumers and enterprise partners. It serves individuals seeking convenient health monitoring and personalized care, as well as large health plans and employers aiming to improve healthcare engagement and outcomes. Everlywell solves the problem of limited access to easy, affordable, and understandable lab testing by enabling users to collect samples at home and receive clinically reviewed results online, complemented by telehealth services and AI-driven personalized health insights. The company has demonstrated strong growth momentum, reaching over 60 million people and delivering nearly 1 billion personalized health insights, solidifying its position as the leading at-home testing brand in the U.S.[1][2][4][5]
Founded in 2014 by Julia Cheek, Everlywell emerged from her vision to democratize lab testing in America, addressing the challenge of difficult and costly access to diagnostic tests. The company gained early traction through innovative direct-to-consumer testing and a pivotal appearance on Shark Tank in 2017, which brought investment and retail partnerships with Target and CVS. In 2021, Everlywell expanded by acquiring PWNHealth and Home Access Health Corporation, forming Everly Health as a parent company to integrate diagnostics, telehealth, and AI-powered care. This evolution reflects a shift from simple at-home tests to a comprehensive digital health platform that combines biomarker intelligence with virtual care and patient engagement[1][2][3].
Everlywell rides the growing trend of consumer-driven healthcare and virtual diagnostics, accelerated by demand for convenient, remote health solutions and data-driven personalized care. The timing is critical as healthcare shifts toward value-based models emphasizing prevention, early detection, and patient engagement. Market forces such as rising chronic disease prevalence, telehealth adoption, and AI integration favor Everlywell’s model. By combining advanced diagnostics with AI and telehealth, Everlywell influences the broader ecosystem by setting new standards for accessible, scalable, and personalized healthcare, bridging gaps between patients, providers, and payers[2][4].
Everlywell is poised to expand its AI capabilities further, enhancing clinician workflows and care coordination while deepening enterprise partnerships. Trends like AI-driven healthcare, personalized medicine, and virtual care will shape its journey, potentially positioning Everlywell as a central player in transforming diagnostics into actionable, continuous health management. Its influence is likely to grow as it integrates more data sources and expands globally, continuing to empower consumers and healthcare systems with smarter, proactive care solutions[2][4].
In summary, Everlywell has evolved from a pioneering at-home lab testing startup into a comprehensive digital health platform leveraging AI to transform how health insights are delivered and acted upon, making healthcare more accessible, personalized, and efficient.
EverlyWell has raised $280.0M in total across 3 funding rounds.
EverlyWell's investors include Alpine Ventures, Goat Capital, Goodwater Capital, Jigsaw VC, Jude Gomila Rolling Fund, Lionheart Ventures, MS&AD Ventures, Passion Capital, Saga, Stride VC, Errol Damelin, Ian Hogarth.
EverlyWell has raised $280.0M across 3 funding rounds. Most recently, it raised $180.0M Series D in December 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2020 | $180.0M Series D | Alpine Ventures, Goat Capital, Goodwater Capital, Jigsaw VC, Jude Gomila Rolling Fund, Lionheart Ventures, MS&AD Ventures, Passion Capital, Saga, Stride VC, Errol Damelin, Ian Hogarth, Louis Beryl, Sam Altman, Sean Park | |
| Apr 1, 2020 | $50.0M Series C | A7V, Alpine Ventures, Goodwater Capital, HealthQuest Capital, NextGen Venture Partners, Ontario Teachers' Pension Plan | |
| Apr 1, 2019 | $50.0M Venture Round | Alpine Ventures, Goat Capital, Goodwater Capital, Jigsaw VC, Jude Gomila Rolling Fund, Lionheart Ventures, MS&AD Ventures, Passion Capital, Saga, Stride VC, Errol Damelin, Ian Hogarth, Louis Beryl, Sam Altman, Sean Park |
